CancerFax
person
verifiedCancerFax Verified
schoolM.D., Ph.D. ยท Sungkyunkwan University

Dr.ย Yoo Youngย Lee

M.D., Ph.D.

Professor, Gynaecologic Cancer Centre, Obstetrics & Gynaecology

corporate_fareSamsung Medical Center, Seoul

check_circleOvarian & Peritoneal Cancer
check_circleMaximal Cytoreductive Surgery
check_circleEndometrial & Uterine Cancers
check_circleRobotic Surgery
INSTITUTION
corporate_fareSamsung Medical Center
DEPARTMENT
scienceObstetrics & Gynaecology โ€“ Gynaecologic Cancer Centre
SPECIALTY
medical_servicesGynaecologic Oncology & Robotic Surgery
LOCATION
location_onSeoul, South Korea
INTERNATIONAL PATIENTS
publicInternational Patients Welcome
person

Yoo Young Lee

M.D., Ph.D.

Prof. Yoo Young Lee is a Professor in the Gynaecologic Cancer Centre, Department of Obstetrics and Gynaecology, at Samsung Medical Center, Sungkyunkwan University School of Medicine in Seoul, South Korea. She specialises in the surgical and multi-modal management of ovarian, peritoneal, endometrial, uterine, and other gynaecologic cancers.

Prof. Lee has been at the forefront of gynaecologic oncology at Samsung Medical Center since 2012, advancing through Clinical Assistant Professor, Clinical Associate Professor, and Clinical Professor before being appointed Professor in 2021. She completed an internationally recognised Gynaecologic Oncology Fellowship at the Princess Margaret Cancer Centre and Sunnybrook Health Sciences Centre, University of Toronto, from 2016 to 2018. Her clinical focus includes maximal cytoreductive surgery, minimally invasive and robotic surgery, fertility-preserving surgery, HIPEC for advanced ovarian cancer, and the management of hereditary gynaecologic cancers. Prof. Lee is cited more than 4,800 times in the peer-reviewed literature and has contributed to landmark international studies on ovarian cancer outcomes and surgical techniques.

calendar_month
M
Visiting Days
public
International Patients

CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Lee at Samsung Medical Center, subject to hospital availability and case acceptance.

stars

Why Consider Prof. Yoo Young Lee?

Prof. Lee combines internationally trained surgical expertise with a deep research background and leadership roles in Asian gynaecologic oncology โ€” making her a sought-after specialist for complex and advanced gynaecologic cancers.

emoji_events
International Fellowship Training
Completed a dedicated Gynaecologic Oncology Fellowship at Princess Margaret Cancer Centre and Sunnybrook Health Sciences Centre, University of Toronto, Canada โ€” among the top-ranked cancer centres globally.
science
4,800+ Research Citations
An active researcher with over 4,800 citations across peer-reviewed journals, contributing to international studies on cytoreductive surgery, HIPEC, and ovarian cancer management.
precision_manufacturing
Robotic & Minimally Invasive Surgery
Performs robotic surgery and minimally invasive procedures for eligible patients, offering reduced recovery times and precise tumour resection within a high-volume cancer centre.
groups
Asian Gynaecologic Oncology Leadership
Serves as Chair of the Asian Society of Gynecologic Oncology Education Committee and Secretary General of the Korean Society of Peritoneal Surface Malignancy.
verified_user

Areas of Specialisation

Advanced surgical and multi-modal treatment for gynaecologic cancers

Prof. Lee's clinical practice covers the full spectrum of gynaecologic oncology, with particular depth in advanced ovarian cancer, peritoneal malignancy, and fertility-preserving surgery.

Clinical Specialities

Ovarian, Peritoneal & Fallopian Tube Cancer

Comprehensive management of advanced-stage disease including surgery and systemic therapy.

starsMaximal Cytoreductive Surgery
  • arrow_rightPrimary debulking surgery (PDS) for advanced ovarian cancer
  • arrow_rightInterval debulking surgery (IDS) following neoadjuvant chemotherapy
  • arrow_rightHIPEC (hyperthermic intraperitoneal chemotherapy) for selected patients
  • arrow_rightBowel resection and complex pelvic surgery during cytoreduction
starsRelapsed Ovarian Cancer
  • arrow_rightSecondary cytoreductive surgery assessment for eligible patients
  • arrow_rightManagement of PARP inhibitor-progressed disease
  • arrow_rightParticipation in clinical trials for recurrent disease (KGOG 3067 / SOCCER-P)

Endometrial, Uterine & Other Gynaecologic Cancers

Surgical and comprehensive care for uterine, vaginal, and hereditary gynaecologic cancers.

starsEndometrial & Uterine Cancer Surgery
  • arrow_rightSurgical staging and treatment for endometrial carcinoma
  • arrow_rightManagement of uterine sarcoma
  • arrow_rightFertility-preserving approaches for eligible patients
starsHereditary Gynaecologic Cancer
  • arrow_rightRisk assessment and management for BRCA-associated cancers
  • arrow_rightCounselling and surveillance for hereditary cancer syndromes
  • arrow_rightProphylactic and risk-reducing surgery where appropriate

Minimally Invasive & Robotic Surgery

Advanced surgical approaches to reduce recovery time and improve precision.

starsRobotic-Assisted Gynaecologic Surgery
  • arrow_rightRobot-assisted laparoscopic surgery for gynaecologic cancers
  • arrow_rightMinimally invasive staging procedures
  • arrow_rightLaparoscopic approaches for eligible early-stage disease
Cancer Types Treated
check_circleOvarian Cancer
check_circlePeritoneal Cancer
check_circleEndometrial Cancer
check_circleUterine Sarcoma
check_circleFallopian Tube Cancer
check_circleVaginal Cancer
check_circleHereditary Gynaecologic Cancer
medical_services

Procedures Performed

Surgical and clinical services at Samsung Medical Center

Prof. Lee offers a wide range of surgical and clinical oncology procedures through the Gynaecologic Cancer Centre at Samsung Medical Center.

Cytoreductive Surgery

Complex Disease

Maximal effort tumour removal for advanced gynaecologic cancers, including complex pelvic and abdominal procedures.

Surgical Approaches
arrow_rightPrimary and interval debulking surgery for ovarian and peritoneal cancer
arrow_rightHIPEC (hyperthermic intraperitoneal chemotherapy) for selected cases
arrow_rightBowel resection and anastomosis during cytoreduction
arrow_rightPelvic exenteration where clinically indicated

Robotic & Minimally Invasive Surgery

Complex Disease

Precision robotic and laparoscopic procedures for gynaecologic cancers.

Minimally Invasive Techniques
arrow_rightRobot-assisted laparoscopic hysterectomy and staging
arrow_rightMinimally invasive lymph node dissection
arrow_rightLaparoscopic assessment for staging and fertility preservation

Multidisciplinary Cancer Management

Multidisciplinary

Integrated oncology care combining surgery, chemotherapy, and targeted therapy planning.

Combined Treatment Planning
arrow_rightNeoadjuvant chemotherapy followed by surgical cytoreduction
arrow_rightPost-surgical systemic therapy including PARP inhibitor maintenance
arrow_rightTumour board review and multidisciplinary case planning

Second Opinion Consultations

Second Opinion

Independent expert review of pathology, imaging, and treatment history for gynaecologic cancer cases.

Case Review
arrow_rightReview of pathology, molecular profiling, and imaging
arrow_rightSurgical resectability and operability assessment
arrow_rightAlternative treatment pathway and clinical trial eligibility review
menu_book

Research & Publications

Peer-reviewed research and international clinical trial contributions

Prof. Lee is an active researcher with more than 4,800 citations in gynaecologic oncology. Her work spans advanced ovarian cancer surgery, HIPEC, peritoneal surface malignancy, and minimally invasive techniques.

Selected Peer-Reviewed Publications
arrow_rightImpact of HIPEC on survival and morbidity after interval debulking surgery in advanced ovarian cancer โ€” SUROVA international study (co-author)
arrow_rightClinical factors associated with prognosis in low-grade serous ovarian carcinoma: experiences at two large institutions in Korea and Taiwan โ€” Scientific Reports, 2020
arrow_rightProton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma โ€” Oncotarget, 2015
arrow_rightWhere is ERAS in the management of advanced ovarian cancer? โ€” Journal of Gynecologic Oncology, 2022 (co-author)
arrow_rightLarge bowel surgery during maximal cytoreductive surgery for advanced ovarian cancer: outcomes by gynecologic oncologist vs general surgeon โ€” GORILLA-3006
Clinical Trial Contributions
arrow_rightContributor โ€” SUROVA international study on HIPEC outcomes after interval debulking surgery in advanced ovarian cancer
arrow_rightInvestigator โ€” KGOG 3067 / SOCCER-P: Randomised phase II study of secondary cytoreductive surgery in relapsed ovarian cancer progressed on PARP inhibitor maintenance
arrow_rightContributor โ€” GORILLA-3006: Comparative outcomes study for large bowel surgery during maximal cytoreductive surgery
Principal Editor โ€“ Journal of Gynecologic Oncology

Prof. Lee serves as a Principal Editor of the Journal of Gynecologic Oncology, reflecting her standing in the international gynaecologic oncology research community.

school

Education & Training

Prof. Lee completed her undergraduate medical training at Kyungpook National University before pursuing residency, fellowship, and doctoral training at Samsung Medical Center and leading international institutions.

Undergraduate
Bachelor of Science (Medicine)
Kyungpook National University, College of Medicine, South Korea
1994 โ€“ 2000
Internship
Internship
Samsung Medical Center, Seoul, South Korea
2000 โ€“ 2001
Residency
Residency โ€“ Obstetrics and Gynaecology
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
2001 โ€“ 2005
Postgraduate
Master of Science (Medicine)
Kyungpook National University, College of Medicine, South Korea
2004 โ€“ 2006
Fellowship
Fellowship โ€“ Obstetrics and Gynaecology
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
2008 โ€“ 2012
Doctoral
Ph.D. in Medicine
Chung-Ang University, College of Medicine, South Korea
2011 โ€“ 2013
International Fellowship
Fellowship โ€“ Gynaecologic Oncology
Princess Margaret Cancer Centre / Sunnybrook Health Sciences Centre, University of Toronto, Canada
2016 โ€“ 2018
Dedicated gynaecologic oncology fellowship at one of North America's foremost cancer centres.
work_history

Clinical Experience

Prof. Lee has been based at Samsung Medical Center's Gynaecologic Cancer Centre since 2012, progressing from Clinical Assistant Professor to full Professor in 2021, with an international fellowship interlude in Toronto from 2016 to 2018.

Professor, Gynaecologic Cancer Centre, Obstetrics & Gynaecology
Samsung Medical Center
Sungkyunkwan University School of Medicine, Seoul
check_circleAdvanced ovarian and peritoneal cancer surgery
check_circleMaximal cytoreductive surgery and HIPEC
check_circleRobotic and minimally invasive gynaecologic surgery
check_circleFertility-preserving surgery for eligible patients
check_circleHereditary gynaecologic cancer management
check_circleInternational clinical research and trial participation
language

Languages & International

Prof. Lee conducts consultations in the following languages.

๐Ÿ‡ฐ๐Ÿ‡ทKorean
๐Ÿ‡ฌ๐Ÿ‡งEnglish
Interpreter Support Available

CancerFax can coordinate professional medical interpreter support for international patients consulting with Prof. Lee.

CancerFax can coordinate professional medical interpreter support for international patients where required.

support_agentHow CancerFax Helps

How CancerFax Helps You Access Dr. Yoo Young Lee

CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Yoo Young Lee's team โ€” with full coordination from initial inquiry to consultation.

description

Medical Report Review

Free review of your pathology results, imaging, molecular profiling, and treatment history โ€” prepared as a structured clinical summary for Dr. Yoo Young Lee's team.

medical_services

Treatment Eligibility Screening

CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Yoo Young Lee before you travel, so you arrive with a clear pathway.

send

Case Submission

We coordinate direct case submission to Dr. Yoo Young Lee's department, including all documentation required for clinical review and appointment scheduling.

calendar_month

Appointment & Consultation Coordination

CancerFax manages appointment scheduling with Dr. Yoo Young Lee's team, confirming availability and aligning timelines with your travel plans.

flight_takeoff

Travel, Visa & Logistics Support

We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.

support_agent

Follow-Up & Continuity of Care

After your consultation or treatment, CancerFax facilitates communication between Dr. Yoo Young Lee's team and your home oncologist for seamless post-treatment follow-up.

quiz

Frequently Asked Questions About Prof. Yoo Young Lee

Samsung Medical Center operates an International Healthcare Centre and actively welcomes international patients. CancerFax can coordinate medical-report review and consultation support for patients seeking an opinion from Prof. Lee, subject to hospital availability and case acceptance.

Prof. Lee specialises in ovarian cancer, peritoneal cancer, endometrial cancer, uterine sarcoma, fallopian tube cancer, vaginal cancer, and hereditary gynaecologic cancers. She is also experienced in the management of robotic and minimally invasive gynaecologic surgery.

Submit your medical reports through CancerFax using the Send Your Reports button. The CancerFax team will review your documents, prepare a structured case summary, and coordinate the next steps with Samsung Medical Center, subject to availability.

Cytoreductive surgery โ€” also called debulking surgery โ€” aims to remove as much tumour as possible in patients with advanced ovarian or peritoneal cancer. Prof. Lee performs both primary debulking surgery (before chemotherapy) and interval debulking surgery (after neoadjuvant chemotherapy), and is experienced with HIPEC (hyperthermic intraperitoneal chemotherapy) for selected patients.

A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and molecular profiling results. The final consultation format and availability depend on the doctor's schedule at Samsung Medical Center.

Prof. Lee has contributed to several international and Korean clinical trials, including the SUROVA HIPEC study, the KGOG 3067 / SOCCER-P trial on secondary cytoreductive surgery in PARP inhibitor-progressed ovarian cancer, and other multicentre studies. CancerFax can explore potential trial eligibility as part of case coordination, subject to current enrolment status.

sendGet Expert Oncology Guidance

Connect with Yoo Young Lee Today

Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.

Free case review ยท No commitment ยท Response within 24 hours ยท Available in 12+ languages

Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.

upload_fileUpload ReportschatWhatsApp